CYP7B1 Antibody (WW-H9) is a mouse monoclonal IgG2a kappa light chain antibody that detects CYP7B1 protein of human origin by western blotting (WB), immunoprecipitation (IP), and enzyme-linked immunosorbent assay (ELISA). CYP7B1 (WW-H9) antibody is available as a non-conjugated anti-CYP7B1 monoclonal isotype antibody. CYP7B1 protein, also known as oxysterol 7-alpha-hydroxylase, plays a crucial role in the alternative bile acid synthesis pathway by metabolizing 25- and 27-hydroxycholesterol, which are important intermediates in cholesterol metabolism. This enzymatic activity is vital for maintaining cholesterol homeostasis and regulating bile acid levels, which are essential for proper digestion and absorption of dietary fats. The gene encoding human CYP7B1 is located on chromosome 8q21.3, and mutations in this gene can lead to significant metabolic disorders, including elevated urinary bile acid excretion, severe cholestasis, cirrhosis, and liver synthetic failure. Understanding the function of CYP7B1 and its metabolic pathways is important for developing therapeutic strategies for conditions related to bile acid synthesis and cholesterol metabolism.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Ordering Information
Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CYP7B1 Antibody (WW-H9) | sc-134309 | 100 µg/ml | $333.00 |